Pain Medicines Road Map

Summary

More about Dr Christina Abdel Shaheed Stay in touch

There is currently no evidence source (in Australia or globally) that has appraised and summarised the evidence on the efficacy and safety of common pain drugs to treat pain in one document. Existing systematic reviews tend to focus on one drug and one pain condition. What is lacking is a comprehensive overview, or ‘Pain Medicines Road Map', which ‘brings it all together'.

Supervisors

Dr Christina Abdel Shaheed , Professor Chris Maher, Professor Andrew McLachlan.

Research location

Institute for Musculoskeletal Health, University of Sydney

Program type

Masters/PHD

Synopsis

The focus of this Masters or PhD opportunity will be to evaluate the efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, gabapentinoids (pregablin and gabapentin), and glucocorticoids for any pain condition. The successful candidate will carry out four overview reviews (one for each drug class). Previous experience in carrying out systematic reviews is recommended but not mandatory. A detailed project plan will be discussed with the supervisors.

Want to find out more?

Interested in this opportunity? Want to know what to do next? Find out all you need to know about the application process including how to approach a potential supervisor via email and how to develop a research proposal.
Browse for other opportunities within the Institute for Musculoskeletal Health, University of Sydney.
Contact us to find out what's involved in applying for a PhD. Domestic students and international students.

Opportunity ID

The opportunity ID for this research opportunity is 2958